The combined administration of circ_CEA siRNA and Dox exhibited synergistic anti-tumor effects in vivo, suggesting that the downregulation of circ_CEA renders GC cells more susceptible to Dox treatment. The gene discussed is CEACAM5; the disease is neoplasm.